Shopping Cart
Remove All
Your shopping cart is currently empty
LTA4H-IN-4 (compound 3) is an orally active inhibitor of LTA4H. It exhibits an IC50 value of 156 μM against hERG and is applicable for inflammation-related research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | LTA4H-IN-4 (compound 3) is an orally active inhibitor of LTA4H. It exhibits an IC50 value of 156 μM against hERG and is applicable for inflammation-related research. |
| In vitro | LTA4H-IN-4 (compound 3) at concentrations ranging from 0 to 10 μM over a period of 4 hours completely inhibits the release of LTB4 in primary peripheral blood mononuclear cells (PBMCs) following stimulation by a calcium ionophore. |
| In vivo | LTA4H-IN-4 (compound 3), administered at 0-300 mg/kg twice daily with a 10-hour interval for 7 days either intravenously or orally, demonstrates significant oral activity in arthritis mouse models, as well as in rats and dogs, without notable changes in animal weight or any significant adverse effects observed in toxicological studies. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.